Follistatin 344

Follistatin 344 is a single-domain glycoprotein consisting of 344 amino acids that functions as the body's primary endogenous inhibitor of myostatin — the protein that sets the genetic ceiling on muscle growth. Myostatin (also called GDF-8) is a member of the TGF-beta superfamily and acts as a powerful negative regulator of skeletal muscle mass. Animals with natural myostatin mutations (Belgian Blue cattle, Bully Whippets) exhibit dramatic muscular hypertrophy. Follistatin binds directly to myostatin with high affinity, neutralizing its activity and effectively removing the biological brake on muscle growth.

Follistatin's mechanism is elegantly direct: it binds to myostatin in the extracellular space, forming a Follistatin-myostatin complex that prevents myostatin from binding to its receptor (activin receptor type IIB, ActRIIB). This neutralization removes the anti-anabolic signal that myostatin constitutively delivers to muscle tissue, resulting in enhanced muscle protein synthesis, satellite cell proliferation, and myofiber hypertrophy. Importantly, Follistatin also binds and neutralizes activin A, another TGF-beta family member with muscle-inhibiting properties, providing a dual anti-catabolic effect. The 344-amino-acid isoform (as opposed to the shorter 315 isoform) has greater heparin-binding affinity, which concentrates it near cell surfaces and may improve its local activity at muscle tissue.

Research on follistatin demonstrates significant increases in skeletal muscle mass, strength, and satellite cell activity. Gene therapy studies using follistatin vectors have produced the most dramatic results: non-human primate studies showed sustained increases in muscle mass and strength persisting for years. Recombinant follistatin research shows dose-dependent increases in muscle protein synthesis and reductions in myostatin-mediated catabolic signaling. The compound has also generated interest in muscular dystrophy research, where myostatin inhibition can partially compensate for the progressive muscle loss characteristic of the disease.

Follistatin 344 is suited for advanced researchers investigating myostatin biology, genetic limits on muscle growth, muscle wasting conditions, and the TGF-beta signaling pathway. It represents the most direct approach to removing the body's endogenous ceiling on muscular development.

Reconstitute the 1mg vial carefully with 1ml bacteriostatic water — Follistatin 344 is a large, complex glycoprotein that requires gentle handling. Roll the vial to dissolve; do not shake. Administer via subcutaneous injection, typically 100-200mcg per day. Protocols typically run 10-30 days, with researchers noting the most pronounced effects during the first 10-14 days. Follistatin 344 has a relatively short half-life of several hours, supporting once-daily dosing. Store at 2-8C after reconstitution. Lyophilized powder should be stored at -20C. Due to the compound's complexity and cost, precise reconstitution and careful storage are essential.

---

## Nootropics & Cognitive